DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Laniquidar
Laniquidar
WO 2017/048702 Al
Natural Products As Alternative Choices for P-Glycoprotein (P-Gp) Inhibition
MINI-REVIEW Cancer Multidrug Resistance (MDR): a Major
Binding Cassette Proteins (ABCB1 and ABCC1)
Pathways of Chemotherapy Resistance in Castration-Resistant Prostate Cancer
Stembook 2018.Pdf
Tumour Stem Cells and Drug Resistance
United States Patent (10) Patent No.: US 9,605,003 B2 Castro Et Al
(12) Patent Application Publication (10) Pub. No.: US 2016/0220537 A1 GARNER Et Al
The Pyrazolo[3,4-D]Pyrimidine Derivative, SCO-201, Reverses Multidrug Resistance Mediated by ABCG2/BCRP
State of the Art of Overcoming Efflux Transporter Mediated Multidrug Resistance of Breast Cancer
Non-Commercial Use Only
A Pharmacodynamic Study of Docetaxel in Combination with the P-Glycoprotein Antagonist, Tariquidar (XR9576) in Patients with Lung, Ovarian, and Cervical Cancer
Pharmacokinetic Optimization of Docetaxel Dosing Frederike Engels
Ellagic Acid and Schisandrins: Natural Biaryl Polyphenols with Therapeutic Potential to Overcome Multidrug Resistance in Cancer
Coadministration of Antiepileptic Drugs and P-Glycoprotein Inhibitors of Flavonoid-Type: a Strategy to Overcome the Drug Resistance in Epilepsy
Efflux Pump‑Mediated Resistance in Chemotherapy
The Effect of St John's Wort on the Pharmacokinetics of Docetaxel
Top View
Pharmaceutical Formulations with P-Glycoprotein Inhibitory Effect As Promising Approaches for Enhancing Oral Drug Absorption and Bioavailability
The Role of ABC Transporters in Anticancer Drug Transport
(12) Patent Application Publication (10) Pub. No.: US 2012/0277199 A1 Ye Et Al
Resistance to Taxanes 329
Targeting Multidrug Resistance with Small Molecules for Cancer Therapy
Potential for Improvement of Docetaxel-Based Chemotherapy: a Pharmacological Review
Β-Elemene, a Compound Derived from Rhizoma Zedoariae, Reverses Multidrug Resistance Mediated by the ABCB1 Transporter